EGFR and neoplasm: Ohno et al. showed that EVs engineered to present a fusion protein of the transmembrane domain of platelet-derived growth factor receptor and the GE11 peptide could deliver a tumor suppressor miRNA (let-7a) to epidermal growth factor receptor- (EGFR-) expressing breast cancer cells [67].